New diabetes clinical trial: Effects of Sitagliptin in Individuals With Genetically Decreased DPP4

Published on: March 26, 2020 at 09:30PM
Conditions:   Genetics Disease;   Type2 Diabetes;   Heart Failure
Interventions:   Drug: Sitagliptin 100mg;   Drug: Placebo Oral Tablet
Sponsor:   University of Pennsylvania
Suspended
https://ift.tt/2UH3Ssh